PhageXpert™ System
Diagnostic for phage susceptibility testing
Pre-clinicalActive
Key Facts
Indication
Diagnostic for phage susceptibility testing
Phase
Pre-clinical
Status
Active
Company
About Inteliphage
Inteliphage is a private, pre-revenue biotech company developing a comprehensive platform to make personalized bacteriophage therapy a practical clinical reality. Its core offering is the PhageXpert™ system, an automated phage susceptibility (phagogram) workflow designed to rapidly match therapeutic phages from its curated library to a patient's specific bacterial infection. By addressing the critical logistical and diagnostic bottlenecks in phage therapy, Inteliphage aims to position itself as a key enabler in the fight against antibiotic-resistant infections, particularly those caused by ESKAPE pathogens.
View full company profile